Remember meForgot password?
    Log in with Twitter

FDA Turns to Industry for Data Mining

By Tim Watson
Posted Apr 4, 2013 in Technology
The Food and Drug Administration has released three solicitation documents aimed at monitoring the internet through data mining.
The fist request for industry is for a company to go through more than 20 million biomedical journal abstracts based in the National Library of Medicine in order to find drugs that have large numbers of negative events associated with them.
The Office of Clinical Pharmacology, within FDA, has requested work meant to uncover how drugs undergoing the Agency approval process are faring with the public.
The company would track any positive or negative side effects people who are taking the drug are having.
The last solicitation is for a program that would track the web for illegal sales of drugs, medical devices, cosmetics and veterinary products, counterfeit food and adulterated or misbranded vaccines.

Latest News
Top News